Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8215419 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 8 Pages |
Abstract
C-TPF yields high ORR and CR as induction treatment in unresectable SCCHN. However, hematologic toxicity is too high to recommend this regimen at the current dose.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ricard MD, PhD, Silvia MD, Juan J. MD, PhD, Jose A. MD, PhD, Alicia MD, Carlos MD, PhD, Joan MD, PhD, Antonio MD, PhD, Manel MD, PhD, Beatriz MD, Elvira MD, PhD, Miren MD, Yolanda MD, Juan J. MD, PhD,